The cannabis market has begun to garner worldwide attention as more countries move to adopt cannabis legislation. Primarily, most countries are looking to adopt medical cannabis laws. Countries that have adopted medical legislation are leveraging cannabis to treat certain medical applications such as cancer, chronic pain, epilepsy, Alzheimer’s, and Parkinson’s disease. Throughout the past year, the cannabis industry has made significant milestones as the U.S. Food and Drug Administration approved its first cannabis-derived drug to treat epilepsy in children. Shortly after, the U.S. Drug Enforcement Agency removed CBD, or cannabidiol, off the Schedule 1 list. CBD-based products that have less than 0.1% THC concentrate will now be considered a Schedule 5 drug, as long as the medication has been approved by the FDA. Furthermore, the FDA recently scheduled a public hearing to be held in May as the agency looks to legalize CBD in food and drinks. The combination of these events has led to the exponential growth of the overall cannabis market. Moreover, as legalization efforts continue, other countries are expected to be influenced and potentially follow in legalizing cannabis. According to data compiled by Grand View Research, the global legal marijuana market was valued at USD 9.3 Billion and is expected to reach USD 146.4 Billion by the end of 2025. Additionally, the market is projected to register a CAGR of 34.6%. CLS Holdings, USA Inc. (OTC: CLSH) (CSE: CLSH.U), Charlotte’s Web Holdings, Inc. (OTC: CWBHF) (CSE: CWEB), Cresco Labs Inc. (OTC: CRLBF) (CSE: CL), Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE), Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT)
Research and studies conducted within the cannabis industry have helped in adding credibility to the plant. However, the FDA ruled that due to the lack of large-scale and efficient clinical trials, the agency cannot approve cannabis as a registered treatment, yet. Now, researchers and companies involved within the industry are expanding their studies to help expand the cannabis market further. The FDA’s concern over cannabis becoming a legitimate medicine alternative signals the steps the market has taken. Decades ago, cannabis was internationally illegal. Now, countries including Australia, Canada, Columbia, Germany, the Netherlands, Spain, and the U.S. have all adopted cannabis legislation of some form. Moving forward, as more governments and regulatory agencies focus on the topic of cannabis legalization, the cannabis industry can become the next emerging global market. “It’s critical that we address these unanswered questions about CBD and other cannabis and cannabis-derived products to help inform the FDA’s regulatory oversight of these products — especially as the agency considers whether it could be appropriate to exercise its authority to allow the use of CBD in dietary supplements and other foods,” outgoing FDA Commissioner Scott Gottlieb recently said in a statement.
CLS Holdings, USA Inc. (OTCQB: CLSH) (CSE: CLSH.U) is also listed on the Canadian Securities Exchange under the ticker (CSE: CLSH.U). Earlier last week, the Company announced that, “since acquiring Oasis Cannabis Dispensary in Las Vegas, Nevada, CLS Holdings USA, Inc. (OTCQB: CLSH) (CSE: CLSH.U) has been working to elevate the entire customer experience behind cannabis. The catchphrase “New Oasis, Same Faces” assures customers that they will still receive the same care and attention they’ve come to expect from Oasis Cannabis, only now in a totally redesigned, modern, and fresh facility. The new space is more accessible, inviting and vibrant, with the same friendly and knowledgeable staff. Over the past few months, walls have been torn down and the color scheme have been modernized from lime green to bright white with blue accents, evoking a vibrant and calming feel. LED lit display cases are purposefully and openly situated, allowing customers ample room to explore products. The large white bud bar hosts the budtender, who is able to curate a better user experience through education and a diverse product selection. At the heart of the renovation is improving customer experience – but the company’s dedication to education, compassionate care, and community enrichment remain the same.
All are welcome to join the Oasis Cannabis Grand Reopening Party, which will take place at the dispensary on Saturday April 6th 2019 from 12:00pm – 10:00pm. The event will feature vendors on-site, live art, live music, food trucks, and special prices. The dispensary is located at 1800 Industrial Rd #180, Las Vegas, NV 89102.
About Oasis Cannabis: Oasis Cannabis has operated a cannabis dispensary in the Las Vegas market since dispensaries first opened in Nevada in 2015 and has been recognized as one of the top marijuana retailers in the state. Its location within walking distance to the Las Vegas Strip and Downtown Las Vegas in combination with its delivery service to residents allows it to efficiently serve both locals and tourists in the Las Vegas area. In February 2019, it was named “Best Dispensary for Pot Pros” by Desert Companion Magazine.
In August 2017, the company commenced wholesale offerings of cannabis in Nevada with the launch of its City Trees brand of cannabis concentrates and cannabis-infused products. http://oasiscannabis.com
About City Trees: Founded in 2017, City Trees is a Nevada based cannabis cultivation, production and distribution company. Offering a wide variety of products with consistent results, City Trees is one the fastest growing wholesale companies in the industry. Its products are now available at 40 dispensaries. https://citytrees.com
About CLS Holdings USA, Inc: CLS Holdings USA, Inc. (OTCQB:CLSH) (CSE:CLSH), is a diversified cannabis company that acts as an integrated cannabis producer and retailer through its Oasis Cannabis subsidiaries in Nevada, and plans to expand to other states. CLS stands for “Cannabis Life Sciences,” in recognition of the Company’s patented proprietary method of extracting various cannabinoids from the marijuana plant and converting them into products with a higher level of quality and consistency. The Company’s business model includes licensing operations, processing operations, processing facilities, sale of products, brand creation and consulting services.”
For our latest “Buzz on the Street” Show featuring CLS Holdings, USA Inc. recent corporate news, please head over to:
Charlotte’s Web Holdings, Inc. (OTCQX: CWBHF) (CSE: CWEB) is the market leader in the production and distribution of innovative hemp-based cannabidiol wellness products. Recently, Charlotte’s Web Holdings, Inc. surpassed 3,000 retail locations across the United States. At the end of 2017, Charlotte’s Web products were sold in approximately 2,000 locations. The Company had recently that it surpassed its 2018 year-end goal of 3,000 locations during the 3rd quarter. With CBD gaining mainstream market momentum, Charlotte’s Web, the industry pioneer and category leader in hemp-based CBD, has expanded its suite of product offerings across a wider variety of retailers, from small specialty health food stores to now including regional pharmacy and grocery chains. “Firstly, I would like to commend our incredible and committed staff who worked tirelessly to achieve this milestone,” stated Charlotte’s Web Chief Executive Officer Hess Moallem. “I would also like to thank our dedicated retail partners for their continued support of our mission and for valuing the trust that is closely associated with our brand name.”
Cresco Labs Inc. (OTCQX: CRLBF) (CSE: CL) and CannaRoyalty Corp. d/b/a Origin House (CSE: OH) (OTCQX: ORHOF) recently announced that they have entered into a definitive agreement, pursuant to which Cresco Labs will acquire all of the issued and outstanding shares of Origin House. Under the terms of the Agreement, holders of common shares of Origin House will receive 0.8428 subordinate voting shares of Cresco Labs for each Origin House Share. Origin House has become a leading distributor and provider of brand support services in California, the world’s largest regulated cannabis market. Origin House’s proven strategy has been to build relationships with established dispensaries, build partnerships with established market-leading brands, develop promising cannabis product companies, and then leverage its full suite of support services to transform those products into strong California consumer brands. Origin House delivers over 50+ cannabis brands to more than 500 dispensaries in California, representing approximately 60% market penetration. “The acquisition of Origin House is another example of our focused and disciplined approach to creating a meaningful presence in key cannabis markets through excellence in brand development and distribution,” said Cresco Labs Chief Executive Officer and Co-founder Charlie Bachtell.
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) is the leader in pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric disorders. Zynerba Pharmaceuticals, Inc. recently announced that it has initiated the Phase 2 BRIGHT (An Open-Label Tolerability and Efficacy Study of ZYN002 Administered as a Transdermal Gel to Children and Adolescents with Autism Spectrum Disorder) trial. The trial will assess the safety, tolerability and efficacy of Zygel (previously referred to as ZYN002) for the treatment of child and adolescent patients with Autism Spectrum Disorder (ASD). The Company expects to present topline data from this study in the first half of 2020. Clinical and anecdotal data suggest that CBD may modulate the EC system and improve certain core social and behavioral autism-related symptoms, including social avoidance and anxiety. “Autism spectrum disorder can have a devastating impact on a child and their family,” said Armando Anido, Chairman and Chief Executive Officer of Zynerba. “The medical need is significant and unmet despite high awareness and advocacy efforts. Though there has been an accelerating rate of diagnosis, to date there are only two FDA approved products indicated for the treatment of ASD symptoms.”
Neptune Wellness Solutions Inc. (NASDAQ: NEPT) (TSX: NEPT) specializes in the extraction, purification and formulation of health and wellness products. Neptune Wellness Solutions Inc. recently announced that it had completed its initial commercial production lots and is now shipping cannabis extracts from its licensed, GPP facility in Sherbrooke, Quebec. “The quality of the extracts in Neptune’s first production runs at our state-of-the-art facility has been terrific, and we are proud to begin deliveries. This marks an important step forward in the execution of our vision to lever our decades of extraction and wellness industry experience towards becoming the world’s leader in the extraction, purification and formulation of value-added, differentiated cannabis products,” said Jim Hamilton, President and Chief Executive Officer of Neptune.
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Follow and talk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
Suning Finance Receives AAA Rating for Domestic Credit
On February 14th, Suning Finance entered the ranks of the highest domestic credit rating for the first time. Its long-term credit rating was determined as AAA, and its rating outlook was “stable”. Currently, only 52 private enterprises nationwide have received AAA ratings. It means that Suning Finance has obtained the same credit rating as large state-owned commercial banks and national joint-stock commercial banks.
Regarding the above decision, United Credit believes that Suning Finance has a strong shareholder background and capital strength. After years of development, it has now established a diversified financial main business structure, relying on the resource advantages of the Suning ecosystem and the omni-channel layout of O2O integration. The financial business scale and income continued to grow rapidly.
As a pioneer of online-to-offline (O2O) finance in China, Suning Finance is positioned as a fintech company featuring O2O integration and development. It has always adhered to and practiced the development model of “scenario finance + fintech = inclusive finance”, focusing on supply chain finance, commercial finance, consumer finance, payments, wealth management, and fintech export “5 + 1” core businesses.
In 2019, Suning Finance successfully completed the C round of tens of billions of financing, the post-investment valuation reached 56 billion, the transaction volume exceeded the trillion marks for three consecutive years, and the number of active customers exceeded 70 million. Suning Pay daily offline scan code breakthrough 100,000 transactions, the supply chain financial investment exceeded 100 billion. And has successfully obtained 2 international syndicated loans, and successively issued 6 phases of supply chain finance ABS and 1 phase of consumer finance ABS, which fully demonstrates that Suning Finance’s business capabilities, asset quality, and market reputation have been highly recognized by domestic and foreign financial institutions.
Based on the root ‘innovative financial technology leads the development’, Suning Finance keeps enhancing its technological capabilities, especially the block chain techs to apply in many scenarios, such as data sharing, payment, mortgage and BaaS. In the future, Suning Finance will continue to provide premium financial services and operate under the concept of integrity, stable and discretion to become a reliable and widely influential comprehensive financial service company.
SOURCE Suning Holdings Group
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Opera Limited of Class Action Lawsuit and Upcoming Deadline – OPRA
Pomerantz LLP announces that a class action lawsuit has been filed against Opera Limited (“Opera” or the “Company”) (NASDAQ: OPRA) and certain of its officers. The class action, filed in United States District Court for the Southern District of New York, and indexed under 20-cv-00674, is on behalf of a class consisting of all persons and entities other than Defendants who purchased or otherwise acquired: (a) Opera American depositary shares (“ADSs”) pursuant and/or traceable to the Company’s initial public offering commenced on or about July 27, 2018 (the “IPO” or “Offering”); and/or (b) Opera securities between July 27, 2018 and January 15, 2020, both dates inclusive (the “Class Period”). Plaintiff pursues claims against the Defendants under the Securities Act of 1933 (the “Securities Act”) and the Securities Exchange Act of 1934 (the “Exchange Act”).
If you are a shareholder who purchased Opera securities pursuant and/or traceable to the IPO and/or during the Class Period, you have until March 24, 2020, to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com. To discuss this action, contact Robert S. Willoughby at firstname.lastname@example.org or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 9980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
Opera was founded in 1996 and is headquartered in Oslo, Norway. The Company, through its subsidiaries, provides mobile and Personal Computer web browser applications in Ireland, Russia, and internationally, under the Opera Mini, Opera for Android, Opera Touch, and Opera for Computers brand names.
Opera has also increasingly invested in its fintech businesses, providing mobile loan and financing applications marketed to Kenya, Nigeria, and India, under the OKash, OPesa, CashBean, and OPay brand names, which are offered on Google LLC’s (“Google”) Play Store marketplace, as downloadable applications.
On August 9, 2018, Opera completed its IPO, issuing 9,600,000 ADSs priced at $12.00 per share, raising approximately $115.2 million in proceeds before underwriting discounts and commissions, and other expenses.
The Complaint alleges that the offering documents were negligently prepared and, as a result, contained untrue statements of material fact or omitted to state other facts necessary to make the statements made not misleading and were not prepared in accordance with the rules and regulations governing their preparation. Additionally, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company’s business, operational and compliance policies. Specifically, the Offering Documents and Defendants made false and/or misleading statements and/or failed to disclose that: (i) Opera’s sustainable growth and market opportunity for its browser applications was significantly overstated; (ii) Defendants’ funded, owned, or otherwise controlled loan services applications and/or businesses relied on predatory lending practices; (iii) all the foregoing, once revealed, were reasonably likely to have a material negative impact on Opera’s financial prospects, especially with respect to its lending applications’ continued availability on the Google Play Store; and (iv) as a result, the Offering Documents and Defendants’ statements were materially false and/or misleading and failed to state information required to be stated therein.
On January 16, 2020, Hindenburg Research (“Hindenburg”) published a report asserting that Hindenburg had “a 12-month price target of $2.60 on Opera, representing a 70% downside.” Among other issues, Hindenburg reported that Opera’s “browser market share is declining rapidly, down ~30% since its IPO”; that Opera was involved in “predatory short-term loans in Africa and India, deploying deceptive ‘bait and switch’ tactics to lure in borrowers and charging egregious interest rates ranging from ~365-876%”; that Opera’s lending business applications, many of which are offered on Google’s Play Store—particularly, OKash, OPesa, CashBean, and Opay—were “in black and white violation of numerous Google rules” aimed at “curtail[ing] predatory lending”; and that consequently, Opera’s entire lending business was “at risk of disappearing or being severely curtailed when Google notices” Opera’s alleged violation of its rules.
On this news, Opera’s ADS price fell $1.69 per share, or 18.74%, to close at $7.33 per share on January 16, 2020.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
SOURCE Pomerantz LLP
Addepar Broadens Reach with Expanded Offerings for RIAs
Addepar, Inc., a leading technology platform for wealth management, announced a number of releases aimed at helping RIAs that serve a variety of client types excel in an increasingly competitive market. The new capabilities and features make it easier than ever for firms to adopt Addepar’s modern technology stack, streamline their operations and offer a truly differentiated client experience powered by best in class data, analytics and reporting.
“As the wealth management industry continues to undergo a dramatic transformation, we’re making good on our goal to meet wealth advisors where they are. We’re delivering new functionality in our platform that empowers RIAs to navigate these changes with purpose-built, intuitive solutions so that they can deliver lasting value to clients and grow their business for years to come,” said Addepar CEO Eric Poirier.
Making it easier for RIAs to modernize their tech stack
For established RIAs who want to modernize their reporting technology but find it daunting to make the switch, Addepar is introducing a broader and more flexible set of data migration options to efficiently and precisely fulfill each client’s data onboarding needs. This includes a newly introduced “Advent Converter,” which streamlines migrating data from Advent’s APX and Axys systems into Addepar. Addepar will continue investing in additional data management and conversion solutions to make it easy for any firm to upgrade to Addepar’s technology.
Addressing emerging demand and delivering more client value
Addepar’s strong traction with large RIA firms, banks and broker-dealers has exposed a previously unmet need in the market: the power to use Addepar’s platform for all advisor teams, from those with ultra-high net worth clients to those who serve the mass affluent. Today, the company is introducing AddeparGoSM, an offering that tailors Addepar’s software to the specific needs of these larger firms. AddeparGo is designed with a set of features, capabilities and custodial data feeds that optimize for speedy implementation and make it easy for larger firms who have a range of advisor teams to adopt. The company is making AddeparGo available to key partners and clients now, and will continue shaping this offering based on feedback.
Helping the back-office streamline operations and scale productivity
Many well-established firms have turned to Addepar for its ability to support sizable and complex implementations and provide data aggregation, analytics and reporting at scale. To offer even greater support, the company is pleased to announce the release of Addepar Teams. Teams is a set of advanced controls and permissions to serve firms that need to grant varying access by team, branch, role and functional responsibility. This set of digital capabilities dramatically simplifies the previously time-intensive and error-prone operational process of managing reporting controls, while achieving legal, risk and compliance goals.
Latest News7 months ago
Galaxy Digital Announces Approval of License to Underwrite Registered Public Offerings of Securities
11 months ago
The Green Organic Dutchman Receives Global Awards for New Website
Fintech10 months ago
Ally Financial Partners with Better.com to Create End-to-End Digital Mortgage Experience
Latest News8 months ago
Chinsay’s Intelligent Contract Platform Enables Rio Tinto & Cargill to Complete the First Fully Digitalised Iron Ore Trade
Latest News7 months ago
Core Scientific launches the first AIRI-Ready Datacenter
Fintech8 months ago
PremFina Makes Final Shortlist for Hottest FinTech Startup in Europe in The Europas Awards
Fintech6 months ago
Experian A/NZ acquires Australian fintech Look Who’s Charging to bolster open data offering
Fintech7 months ago
Apex Clearing Releases ‘Millennial 100’ Stock Pulse Report